KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $1.2 million.

  • Staar Surgical's Change in Inventory rose 1402.38% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 million, marking a year-over-year increase of 5932.55%. This contributed to the annual value of $10.0 million for FY2024, which is 3036.7% down from last year.
  • Staar Surgical's Change in Inventory amounted to $1.2 million in Q3 2025, which was up 1402.38% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Change in Inventory registered a high of $6.3 million during Q1 2025, and its lowest value of -$1.3 million during Q3 2021.
  • Moreover, its 5-year median value for Change in Inventory was $1.4 million (2022), whereas its average is $2.3 million.
  • Per our database at Business Quant, Staar Surgical's Change in Inventory tumbled by 30040.73% in 2021 and then soared by 46398.16% in 2025.
  • Quarter analysis of 5 years shows Staar Surgical's Change in Inventory stood at $1.2 million in 2021, then skyrocketed by 209.31% to $3.8 million in 2022, then rose by 14.82% to $4.4 million in 2023, then fell by 7.93% to $4.0 million in 2024, then tumbled by 69.19% to $1.2 million in 2025.
  • Its Change in Inventory stands at $1.2 million for Q3 2025, versus $4.9 million for Q2 2025 and $6.3 million for Q1 2025.